Rchr
J-GLOBAL ID:201801020005844800   Update date: Sep. 04, 2024

Kambayashi Yumi

カンバヤシ ユミ | Kambayashi Yumi
Affiliation and department:
Research field  (1): Other
Research theme for competitive and other funds  (4):
  • 2022 - 2025 PAI-1・免疫チェックポイント相互阻害による新規免疫療法の開発
  • 2020 - 2022 LL37 might promote local invasion of melanoma by the stimulation of melanoma cells and tumor-associated macrophages
  • 2016 - 2019 Development of novel immune therapy for melanoma by targeting tumor associated macrophages
  • 2016 - 2018 Possible mechanisms of induction of immunotolerance in appocrine-origin skin tumors
Papers (139):
  • Yusuke Muto, Yumi Kambayashi, Hiroshi Kato, Satoru Mizuhashi, Takamichi Ito, Takeo Maekawa, Shoichiro Ishizuki, Hiroshi Uchi, Shigeto Matsushita, Yuki Yamamoto, et al. Three-Year Analysis of Adjuvant Therapy in Postoperative Melanoma including Acral and Mucosal Subtypes. Cancers. 2024. 16. 15
  • Taku Fujimura, Koji Yoshino, Hiroshi Kato, Satoshi Fukushima, Shoichiro Ishizuki, Atsushi Otsuka, Shigeto Matsushita, Ryo Amagai, Yusuke Muto, Emi Yamazaki, et al. Phase II, multicenter study of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab for treating anti-PD-1 antibody-refractory malignant melanoma: TM5614-MM trial. The British journal of dermatology. 2024
  • Yusuke Muto, Yumi Kambayashi, Hiroshi Kato, Satoshi Fukushima, Takamichi Ito, Takeo Maekawa, Yasuhiro Fujisawa, Koji Yoshino, Hiroshi Uchi, Shigeto Matsushita, et al. Adverse events associated with postoperative outcomes of adjuvant anti-PD-1 antibody therapy in both acral and non-acral cutaneous melanomas: A multicenter, observational, post hoc analysis study. The Journal of dermatology. 2023
  • Yusuke Muto, Yumi Kambayashi, Hiroshi Kato, Satoshi Fukushima, Takamichi Ito, Takeo Maekawa, Ishizuki Shoichiro, Hiroshi Uchi, Shigeto Matsushita, Yuki Yamamoto, et al. Postoperative adjuvant therapy for120 melanoma patients, including acral and mucosal subtypes: A multicenter, observational study of two-year follow-up results. The British journal of dermatology. 2023
  • Taku Fujimura, Takeo Maekawa, Hiroshi Kato, Takamichi Ito, Shigeto Matsushita, Koji Yoshino, Yasuhiro Fujisawa, Shoichiro Ishizuki, Kojiro Segawa, Jun Yamamoto, et al. Treatment for taxane-resistant cutaneous angiosarcoma: A multicenter study of 50 Japanese cases. The Journal of dermatology. 2023
more...
MISC (94):
Lectures and oral presentations  (14):
  • ドセタキセル療法で7年間CRを維持している頭部血管肉腫の1例
    (日本皮膚悪性腫瘍学会学術大会プログラム・抄録集 2019)
  • ダブラフェニブ・トラメチニブ療法中に生じた重症多形滲出性紅斑の1例
    (西日本皮膚科 2018)
  • Lichen planus follicularis tumidusとの鑑別を要した小児のmilia en plaqueの1例
    (日本皮膚科学会雑誌 2018)
  • 乳房外パジェット病における免疫寛容のメカニズム
    (日本皮膚悪性腫瘍学会学術大会プログラム・抄録集 2016)
  • 表皮細胞におけるpSTAT染色パターンからみる炎症性皮膚疾患
    (Journal of Environmental Dermatology and Cutaneous Allergology 2015)
more...
Education (2):
  • 2011 - 2015 東北大学大学院 医学部 医学系研究科
  • 2000 - 2006 Tokyo Women's Medical University Faculty of Medicine
Professional career (1):
  • Ph.D (Tohoku University)
Awards (1):
  • 2016 - 東北大学大学院医学系研究科女子大学院学生奨励賞(七星賞)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page